Xilloc was founded on a clear, ambitious conviction: a cranial implant should not be standard, but should fit perfectly with a patient’s unique anatomy. What once started as an innovative view on patient-specific implants grew into a specialised company in CMF solutions, in which digital technology, medical knowledge and high-quality engineering come together.
Today, we develop implants and workflows that help surgeons carry out complex procedures better prepared, more predictably and with greater confidence.
That development has never been purely technical. From the very beginning, Xilloc has been about collaboration: with surgeons, with hospitals and with experts who understand that behind every design lies a patient, a procedure and a medical responsibility.
That is why we continue to build solutions that not only fit precisely on paper, but truly work in practice. With an eye for anatomy, process, fit and the reality of the operating theatre.
The milestones below show how Xilloc has developed step by step: from pioneering idea to specialised partner in patient-specific CMF implants.
Chief Executive Officer / Owner
Head of Design
Medical Design Engineer
Design & Business Development
QA / RA Manager
Production Engineer
Medical Design Engineer
Office Manager
Production Engineer
In April 2010, the very first patient receives an implant, designed by Maikel Beerens (Xilloc founder) in collaboration with Maastricht University. What begins as an innovative solution for one patient forms the basis for a new way of working: fully aligned with the patient’s anatomy and situation.
In August 2011, Xilloc is officially founded. The step from idea to organisation makes it possible to further develop patient-specific solutions and make them more widely available.
With the introduction of the MedX customer portal, collaboration with surgeons and partners is structured and simplified. It forms the basis for a digital workflow in which design, alignment and production come together.
The first One Stage resection and reconstruction is carried out. Thanks to the combination of patient-specific implants and surgical tools, an approach emerges in which multiple steps come together in one controlled procedure.
Xilloc relocates from MUMC+ to the Brightlands Maastricht Health Campus. In this environment, focused on innovation and collaboration, there is room to continue developing and scaling up.
With the first official distributor, Ovidius Solutions, in the United Kingdom, Xilloc takes the step towards international expansion. An important development in making patient-specific solutions accessible beyond the Netherlands as well.
With the arrival of new management, Milko Wijckmans, and the entry of investor Holland Capital, the organisation is further strengthened. This forms the basis for further professionalisation and growth.
Xilloc achieves EU MDR 2017/745 Class III and ISO 13485 certification, issued by TÜV SÜD as EU Notified Body. This confirms that processes and products meet the highest quality and safety requirements.
With a sharpened strategy, rebrand and a completely new Xilloc Portal, a next phase is ushered in. The focus is on further simplifying processes and further strengthening collaboration with surgeons.
